Recurrent disease in the liver transplant: window to identify and stop gut signals driving autoimmunity

Project Information

StopAutoimmunity

Grant agreement ID: 802544

DOI

10.3030/802544

Project closed

EC signature date 29 January 2019

Start date 1 April 2019

End date 31 March 2024

Funded under

• EXCELLENT SCIENCE - European Research Council (ERC)

Total cost

€ 1 500 000,00

EU contribution

€ 1 500 000,00

Coordinated by

UNIVERSITETET I OSLO
Norway

CORDIS provides links to public deliverables and publications of HORIZON projects.

Links to deliverables and publications from FP7 projects, as well as links to some specific result types such as dataset and software, are dynamically retrieved from OpenAIRE .

Publications

Peer reviewed articles (9)

Suppression of bile acid synthesis as a tipping point in the disease course of primary sclerosing cholangitis

Author(s): Peder R. Braadland; Kai Marcus Schneider; Annika Bergquist; Antonio Molinaro; Anita Lövgren-Sandblom A; Marcus Henricsson; Tom H. Karlsen; Mette Vesterhus; Christian Trautwein; Johannes R Hov; Hanns-Ulrich Marschall
Published in: JHEP Reports, Issue 2022 Aug 18;4(11), 2022, ISSN 2589-5559
Publisher: Elsevier
DOI: 10.1016/j.jhepr.2022.100561

Role of microbiome in autoimmune liver diseases

Author(s): Kai Markus Schneider; Martin Kummen ; Palak J. Trivedi; Johannes R. Hov
Published in: Hepatology, 2023, ISSN 0270-9139
Publisher: John Wiley & Sons Inc.
DOI: 10.1097/hep.0000000000000506

A shared mucosal gut microbiota signature in primary sclerosing cholangitis before and after liver transplantation

Author(s): Mikal Jacob Hole; Kristin Kaasen Jørgensen; Kristian Holm; Peder R. Braadland; Malin Holm Meyer‐Myklestad; Asle Wilhelm Medhus; Dag Henrik Reikvam; Alexandra Götz; Krzysztof Grzyb; Kirsten Muri Boberg; Tom Hemming Karlsen; Martin Kummen; Johannes R. Hov
Published in: Hepatology, Issue 3, 2023, ISSN 0270-9139
Publisher: John Wiley & Sons Inc.
DOI: 10.1002/hep.32773

Altered Gut Microbial Metabolism of Essential Nutrients in Primary Sclerosing Cholangitis

Author(s): Kummen M, Thingholm LB, Rühlemann MC, Holm K, Hansen SH, Moitinho-Silva L, Liwinski T, Zenouzi R, Storm-Larsen C, Midttun Ø, McCann A, Ueland PM, Høivik ML, Vesterhus M, Trøseid M, Laudes M, Lieb W, Karlsen TH, Bang C, Schramm C, Franke A, Hov JR.
Published in: Gastroenterology, Issue 160, 2021, Page(s) 1784-1798, ISSN 0016-5085
Publisher: W. B. Saunders Co., Ltd.
DOI: 10.1053/j.gastro.2020.12.058

Rapid and Bifunctional Chemoselective Metabolome Analysis of Liver Disease Plasma Using the Reagent 4-Nitrophenyl-2H-azirine

Author(s): Weifeng Lin, Lars Gerullat, Peder R Braadland, Anaïs Fournier, Johannes R Hov, Daniel Globisch
Published in: Angew Chem Int Ed Engl, Issue 2024 Jan 18, 2024, Page(s) e202318579, ISSN 1433-7851
Publisher: John Wiley & Sons Ltd.
DOI: 10.1002/anie.202318579

Clinical and biochemical impact of vitamin B6 deficiency in primary sclerosing cholangitis before and after liver transplantation

Author(s): Peder Rustøen Braadland; Annika Bergquist; Martin Kummen; Lars Bossen; Lise Katrine Engesæter; Henrik Mikael Reims; Ida Björk; Krzysztof Grzyb; Andreas Abildgaard; Milada Cvancarova Småstuen; Trine Folseraas; Marius Trøseid; Arve Ulvik; Per Magne Ueland; Espen Melum; Pål-Dag Line; Marte Lie Høivik; Henning Grønbæk; Tom Hemming Karlsen; Mette Vesterhus; Johannes Roksund Hov
Published in: Journal of Hepatology, Issue 79(4), 2023, Page(s) 955-966, ISSN 0168-8278
Publisher: Elsevier BV
DOI: 10.1016/j.jhep.2023.05.038

Protective and aggressive bacterial subsets and metabolites modify hepatobiliary inflammation and fibrosis in a murine model of PSC.

Author(s): Muyiwa Awoniyi; Jeremy Wang; Billy Ngo; Vik Meadows; Jason Tam; Amba Viswanathan; Yunjia Lai; Stephanie Montgomery; Morgan Farmer; Martin Kummen; Louise Thingholm; Christoph Schramm; Corinna Bang; Andre Franke; Kun Lu; Huiping Zhou; Jasmohan S Bajaj; Phillip B Hylemon; Jenny Ting; Yury V Popov; Johannes Roksund Hov; Heather L Francis; Ryan Balfour Sartor
Published in: Gut, Issue 2, 2023, ISSN 0017-5749
Publisher: BMJ Publishing Group
DOI: 10.1136/gutjnl-2021-326500

Colitis ameliorates cholestatic liver disease via suppression of bile acid synthesis

Author(s): Wenfang Gui, Mikal Jacob Hole, Antonio Molinaro, Karolina Edlund, Kristin K. Jørgensen, Huan Su, Brigitte Begher-Tibbe, Nikolaus Gaßler, Carolin V. Schneider, Uthayakumar Muthukumarasamy, Antje Mohs, Lijun Liao, Julius Jaeger, Christian J. Mertens, Ina Bergheim, Till Strowig, Jan G. Hengstler, Johannes R. Hov, Hanns-Ulrich Marschall, Christian Trautwein & Kai Markus Schneider
Published in: Nature Communications, Issue 3304 (2023), 2023, ISSN 2041-1723
Publisher: Nature Publishing Group
DOI: 10.1038/s41467-023-38840-8

Microbial-derived imidazole propionate links the heart failure-associated microbiome alterations to disease severity

Author(s): Sajan C Raju, Antonio Molinaro, Ayodeji Awoyemi, Silje F Jørgensen, Peder R Braadland, Andraz Nendl, Ingebjørg Seljeflot, Per M Ueland, Adrian McCann, Pål Aukrust, Beate Vestad, Cristiane Mayerhofer, Kaspar Broch, Lars Gullestad, Knut T Lappegård, Bente Halvorsen, Karsten Kristiansen, Johannes R Hov, Marius Trøseid
Published in: Genome Medicine, Issue 16, 2024, Page(s) Article number: 27, ISSN 1756-994X
Publisher: BioMed Central
DOI: 10.1186/s13073-024-01296-6